1
|
Schultz MJ, Netzel BC, Singh RH, Pino GB, Gavrilov DK, Oglesbee D, Raymond KM, Rinaldo P, Tortorelli S, Smith WE, Matern D. Laboratory monitoring of patients with hereditary tyrosinemia type I. Mol Genet Metab 2020; 130:247-254. [PMID: 32546364 DOI: 10.1016/j.ymgme.2020.06.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2020] [Revised: 05/31/2020] [Accepted: 06/01/2020] [Indexed: 02/07/2023]
Abstract
BACKGROUND The prognosis of patients with Hereditary Tyrosinemia Type 1 (HT-1) has greatly improved with early detection through newborn screening and the introduction of nitisinone (NTBC) therapy. A recent guideline calls for periodic monitoring of biochemical markers and NTBC levels to tailor treatment; however, this is currently only achieved through a combination of clinical laboratory tests. We developed a multiplexed assay measuring relevant amino acids, succinylacetone (SUAC), and NTBC in dried blood spots (DBS) to facilitate treatment monitoring. METHODS Tyrosine, phenylalanine, methionine, NTBC and SUAC were eluted from DBS with methanol containing internal standards for each analyte and analyzed by liquid chromatography tandem mass spectrometry over 6.5 min in the multiple reaction monitoring positive mode. RESULTS Pre-analytical and analytical factors were studied and demonstrated a reliable assay. Chromatography resolved an unknown substance that falsely elevates SUAC concentrations and was present in all samples. To establish control and disease ranges, the method was applied to DBS collected from controls (n = 284) and affected patients before (n = 2) and after initiation of treatment (n = 29). In the treated patients SUAC concentrations were within the normal range over a wide range of NTBC levels. CONCLUSIONS This assay enables combined, accurate measurement of revelevant metabolites and NTBC in order to simplify treatment monitoring of patients with HT-1. In addition, the use of DBS allows for specimen collection at home to facilitate more standardization in relation to drug and dietary treatment.
Collapse
Affiliation(s)
- Matthew J Schultz
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Brian C Netzel
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Rani H Singh
- Department of Human Genetics and Pediatrics, Emory University, Atlanta, GA, USA
| | - Gisele B Pino
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Dimitar K Gavrilov
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Devin Oglesbee
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Kimiyo M Raymond
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Piero Rinaldo
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Silvia Tortorelli
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA
| | - Wendy E Smith
- Maine Medical Partners Pediatrics Specialty Care, Portland, ME, USA
| | - Dietrich Matern
- Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN, USA.
| |
Collapse
|
2
|
Regier DS, Smith WE, Byers HM. Medical genetics education in the midst of the COVID-19 pandemic: Shared resources. Am J Med Genet A 2020; 182:1302-1308. [PMID: 32323908 PMCID: PMC7264783 DOI: 10.1002/ajmg.a.61595] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Accepted: 04/06/2020] [Indexed: 11/12/2022]
Abstract
In the midst of the COVID‐19 pandemic, it is appropriate that our focus is on patient care and preparation. However, the genetics community is well poised to fill in the educational gap created by medical students transitioning to limiting patient contact, creation of telemedicine patient care, and online learning modules. Our history of agility in learning and teaching is now only inhibited by the time constraints of current clinical demands on the genetics community. This publication is designed to offer ideas and resources for quickly transitioning our education to meet the current demands in the time of a pandemic. Not only will this allow us to continue our strong history of education, it will enhance our strong commitment to using modern educational techniques and tools to address the genetics workforce issues that have defined the recent past. We have the opportunity to aggressively educate for trainees that now have the capacity to learn, and to lead the way in showing how the genetics community rallies together no matter the challenge.
Collapse
Affiliation(s)
- Debra S Regier
- Department of Genetics & Metabolism, Children's National Hospital, Washington, District of Columbia, United States
| | - Wendy E Smith
- Division of Genetics, Maine Medical Center, Portland, Maine, United States
| | - Heather M Byers
- Department of Medical Genetics, Stanford University School of Medicine, Stanford, California, United States
| |
Collapse
|
3
|
Diaz GA, Schulze A, Longo N, Rhead W, Feigenbaum A, Wong D, Merritt JL, Berquist W, Gallagher RC, Bartholomew D, McCandless SE, Smith WE, Harding CO, Zori R, Lichter-Konecki U, Vockley J, Canavan C, Vescio T, Holt RJ, Berry SA. Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients. Mol Genet Metab 2019; 127:336-345. [PMID: 31326288 DOI: 10.1016/j.ymgme.2019.07.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Revised: 06/20/2019] [Accepted: 07/09/2019] [Indexed: 12/31/2022]
Abstract
INTRODUCTION Glycerol phenylbutyrate (GPB) is currently approved for use in the US and Europe for patients of all ages with urea cycle disorders (UCD) who cannot be managed with protein restriction and/or amino acid supplementation alone. Currently available data on GPB is limited to 12 months exposure. Here, we present long-term experience with GPB. METHODS This was an open-label, long-term safety study of GPB conducted in the US (17 sites) and Canada (1 site) monitoring the use of GPB in UCD patients who had previously completed 12 months of treatment in the previous safety extension studies. Ninety patients completed the previous studies with 88 of these continuing into the long-term evaluation. The duration of therapy was open ended until GPB was commercially available. The primary endpoint was the rate of adverse events (AEs). Secondary endpoints were venous ammonia levels, number and causes of hyperammonemic crises (HACs) and neuropsychological testing. RESULTS A total of 45 pediatric patients between the ages of 1 to 17 years (median 7 years) and 43 adult patients between the ages of 19 and 61 years (median 30 years) were enrolled. The treatment emergent adverse events (TEAE) reported in ≥10% of adult or pediatric patients were consistent with the TEAEs reported in the previous safety extension studies with no increase in the overall incidence of TEAEs and no new TEAEs that indicated a new safety signal. Mean ammonia levels remained stable and below the adult upper limit of normal (<35 µmol/L) through 24 months of treatment in both the pediatric and adult population. Over time, glutamine levels decreased in the overall population. The mean annualized rate of HACs (0.29) established in the previously reported 12-month follow-up study was maintained with continued GPB exposure. CONCLUSION Following the completion of 12-month follow-up studies with GPB treatment, UCD patients were followed for an additional median of 1.85 (range 0 to 5.86) years in the present study with continued maintenance of ammonia control, similar rates of adverse events, and no new adverse events identified.
Collapse
Affiliation(s)
- George A Diaz
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Andreas Schulze
- University of Toronto and The Hospital for Sick Children, Toronto, ON, Canada
| | | | | | - Annette Feigenbaum
- University of Toronto and The Hospital for Sick Children, Toronto, ON, Canada
| | - Derek Wong
- David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
| | | | - William Berquist
- Stanford University Medical Center & Lucile Packard Children's Hospital, Stanford, CA, USA
| | | | - Dennis Bartholomew
- Ohio State University and Nationwide Children's Hospital, Columbus, OH, USA
| | - Shawn E McCandless
- Children's Hospital Colorado and University of Colorado Denver, Aurora, CO, USA
| | | | | | | | | | - Jerry Vockley
- Children's Hospital of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | | | | | | | | |
Collapse
|
4
|
Kane MS, Zhao J, Muskett J, Diplock A, Srivastava S, Hauser N, Deeken JF, Niederhuber JE, Smith WE, Vilboux T, Ebrahimi-Fakhari D. EPG5 Variants with Modest Functional Impact Result in an Ameliorated and Primarily Neurological Phenotype in a 3.5-Year-Old Patient with Vici Syndrome. Neuropediatrics 2019; 50:257-261. [PMID: 31226715 DOI: 10.1055/s-0039-1692129] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Congenital disorders of autophagy are multisystem disorders with significant neurological involvement. Ectopic p-granules protein 5 (EPG5)-associated Vici syndrome is a prototypical congenital disorder of autophagy and presents with the cardinal features of agenesis of the corpus callosum, cataracts, cardiomyopathy, immunodeficiency, and oculocutaneous hypopigmentation. The majority of EPG5 variants leading to Vici syndrome are null alleles with only a few missense variants published to date. Here we report a 3.5-year-old male with compound heterozygous EPG5 variants [NM_020964.2: c.772G > T/c.5943-9_5943-5del]. His clinical presentation deviates notably from classic Vici syndrome with a lack of hypopigmentation, cataracts, immunodeficiency, cardiomyopathy, or failure to thrive. Neurological manifestations within the known disease spectrum include early-onset global developmental delay, hypotonia, and postnatal microcephaly. Seizures, hearing loss, or optic nerve atrophy are absent, however. Magnetic resonance imaging demonstrates a thin but fully formed corpus callosum. Based on the ameliorated and primarily neurological phenotype, we hypothesized that the functional impact of the EPG5 variants present would be milder with a higher amount of residual EPG5 expression. Analyses of EPG5 messenger ribonucleic acid (mRNA) in the patient and his parents were performed to examine expression level and splicing; mRNA from a healthy control and a patient with classic Vici syndrome was also included. Aberrant splicing due to the intronic mutation was detected, but no loss of expression. In contrast, we observed a 50% reduction in mRNA expression in classic Vici syndrome patient fibroblasts. These results support a model of disease severity, which correlates to the dosage of EPG5 expression.
Collapse
Affiliation(s)
- Megan S Kane
- Inova Translational Medicine Institute, Inova Health System, Fairfax, Virginia, United States
| | - Jia Zhao
- Inova Translational Medicine Institute, Inova Health System, Fairfax, Virginia, United States
| | - Julie Muskett
- Inova Translational Medicine Institute, Inova Health System, Fairfax, Virginia, United States
| | - Amelia Diplock
- Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
| | - Siddharth Srivastava
- Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
| | - Natalie Hauser
- Inova Translational Medicine Institute, Inova Health System, Fairfax, Virginia, United States
| | - John F Deeken
- Inova Schar Cancer Institute, Inova Health System, Fairfax, Virginia, United States.,Department of Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States
| | - John E Niederhuber
- Inova Translational Medicine Institute, Inova Health System, Fairfax, Virginia, United States.,Genomics and Bioinformatics Research Institute, Fairfax, Virginia, United States.,Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.,Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, Virginia, United States
| | - Wendy E Smith
- Department of Pediatrics, The Barbara Bush Children's Hospital, Main Medical Center, Portland, Maine, United States
| | - Thierry Vilboux
- Inova Translational Medicine Institute, Inova Health System, Fairfax, Virginia, United States
| | - Darius Ebrahimi-Fakhari
- Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
| |
Collapse
|
5
|
Steele EJ, Al-Mufti S, Augustyn KA, Chandrajith R, Coghlan JP, Coulson SG, Ghosh S, Gillman M, Gorczynski RM, Klyce B, Louis G, Mahanama K, Oliver KR, Padron J, Qu J, Schuster JA, Smith WE, Snyder DP, Steele JA, Stewart BJ, Temple R, Tokoro G, Tout CA, Unzicker A, Wainwright M, Wallis J, Wallis DH, Wallis MK, Wetherall J, Wickramasinghe DT, Wickramasinghe JT, Wickramasinghe NC, Liu Y. Reply to commentary by R Duggleby (2019). Prog Biophys Mol Biol 2018; 141:74-78. [PMID: 30419256 DOI: 10.1016/j.pbiomolbio.2018.11.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- Edward J Steele
- CY O'Connor ERADE Village Foundation, Piara Waters, WA, Australia; Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka.
| | - Shirwan Al-Mufti
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Kenneth A Augustyn
- Center for the Physics of Living Organisms, Department of Physics, Michigan Technological University, Michigan, United States
| | | | - John P Coghlan
- University of Melbourne, Office of the Dean, Faculty Medicine, Dentistry and Health Sciences, 3rd Level, Alan Gilbert Building, Australia
| | - S G Coulson
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Sudipto Ghosh
- Metallurgical & Materials Engineering IIT, Kanpur, India
| | - Mark Gillman
- South African Brain Research Institute, 6 Campbell Street, Waverly, Johannesburg, South Africa
| | - Reginald M Gorczynski
- University Toronto Health Network, Toronto General Hospital, University of Toronto, Canada
| | - Brig Klyce
- Astrobiology Research Trust, Memphis, TN, USA
| | - Godfrey Louis
- Department of Physics, Cochin University of Science and Technology Cochin, India
| | | | - Keith R Oliver
- School of Veterinary and Life Sciences Murdoch University, Perth, WA, Australia
| | - Julio Padron
- Studio Eutropi, Clinical Pathology and Nutrition, Via Pompei 46, Ardea, 00040, Rome, Italy
| | - Jiangwen Qu
- Department of Infectious Disease Control, Tianjin Center for Disease Control and Prevention, China
| | - John A Schuster
- Unit for History & Philosophy of Science and Sydney Centre for the Foundations of Science, University of Sydney, Sydney, Australia
| | - W E Smith
- Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Duane P Snyder
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Julian A Steele
- Centre for Surface Chemistry and Catalysis, KU Leuven, Celestijnenlaan 200F, 3001, Leuven, Belgium
| | - Brent J Stewart
- CY O'Connor ERADE Village Foundation, Piara Waters, WA, Australia
| | - Robert Temple
- The History of Chinese Science and Culture Foundation, Conway Hall, London, UK
| | - Gensuke Tokoro
- Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Christopher A Tout
- Institute of Astronomy, The Observatories, Madingley Road, Cambridge, CB3 0HA, UK
| | | | - Milton Wainwright
- Buckingham Centre for Astrobiology, University of Buckingham, UK Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka
| | - Jamie Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Daryl H Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Max K Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - John Wetherall
- School of Biomedical Sciences, Perth, Curtin University, WA, Australia
| | - D T Wickramasinghe
- College of Physical and Mathematical Sciences, Australian National University, Canberra, Australia
| | | | - N Chandra Wickramasinghe
- Buckingham Centre for Astrobiology, University of Buckingham, UK Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Yongsheng Liu
- Henan Collaborative Innovation Center of Modern Biological Breeding, Henan Institute of Science and Technology, Xinxiang, 453003, China Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada
| |
Collapse
|
6
|
Berry SA, Vockley J, Vinks AA, Dong M, Diaz GA, McCandless SE, Smith WE, Harding CO, Zori R, Ficicioglu C, Lichter-Konecki U, Perdok R, Robinson B, Holt RJ, Longo N. Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disorders. Mol Genet Metab 2018; 125:251-257. [PMID: 30217721 DOI: 10.1016/j.ymgme.2018.09.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2018] [Revised: 07/27/2018] [Accepted: 09/02/2018] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Glycerol phenylbutyrate (GPB) is approved in the US and EU for the chronic management of patients ≥2 months of age with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. GPB is a pre-prodrug, hydrolyzed by lipases to phenylbutyric acid (PBA) that upon absorption is beta-oxidized to the active nitrogen scavenger phenylacetic acid (PAA), which is conjugated to glutamine (PAGN) and excreted as urinary PAGN (UPAGN). Pharmacokinetics (PK) of GPB were examined to see if hydrolysis is impaired in very young patients who may lack lipase activity. METHODS Patients 2 months to <2 years of age with UCDs from two open label studies (n = 17, median age 10 months) predominantly on stable doses of nitrogen scavengers (n = 14) were switched to GPB. Primary assessments included traditional plasma PK analyses of PBA, PAA, and PAGN, using noncompartmental methods with WinNonlin™. UPAGN was collected periodically throughout the study up to 12 months. RESULTS PBA, PAA and PAGN rapidly appeared in plasma after GPB dosing, demonstrating evidence of GPB cleavage with subsequent PBA absorption. Median concentrations of PBA, PAA and PAGN did not increase over time and were similar to or lower than the values observed in older UCD patients. The median PAA/PAGN ratio was well below one over time, demonstrating that conjugation of PAA with glutamine to form PAGN did not reach saturation. Covariate analyses indicated that age did not influence the PK parameters, with body surface area (BSA) being the most significant covariate, reinforcing current BSA based dosing recommendations as seen in older patients. CONCLUSION These observations demonstrate that UCD patients aged 2 months to <2 years have sufficient lipase activity to adequately convert the pre-prodrug GPB to PBA. PBA is then converted to its active moiety (PAA) providing successful nitrogen scavenging even in very young children.
Collapse
Affiliation(s)
- Susan A Berry
- University of Minnesota Department of Pediatrics, Minneapolis, MN, USA
| | - Jerry Vockley
- University of Pittsburgh School of Medicine and the Children's Hospital of Pittsburgh, Pittsburgh, PA, USA
| | - Alexander A Vinks
- Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA
| | - Min Dong
- Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA
| | - George A Diaz
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Shawn E McCandless
- University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, CO, USA
| | | | | | | | - Can Ficicioglu
- Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | | | | | | | - Robert J Holt
- Horizon Pharma USA, Inc, Lake Forest, IL, USA; University of Illinois-Chicago, Chicago, IL, USA.
| | | |
Collapse
|
7
|
Steele EJ, Al-Mufti S, Augustyn KA, Chandrajith R, Coghlan JP, Coulson SG, Ghosh S, Gillman M, Gorczynski RM, Klyce B, Louis G, Mahanama K, Oliver KR, Padron J, Qu J, Schuster JA, Smith WE, Snyder DP, Steele JA, Stewart BJ, Temple R, Tokoro G, Tout CA, Unzicker A, Wainwright M, Wallis J, Wallis DH, Wallis MK, Wetherall J, Wickramasinghe DT, Wickramasinghe JT, Wickramasinghe NC, Liu Y. Reply to editorial and commentaries on Steele, Al-Mufti, Augustyn, Chandrajith, Coghlan, Coulson et al. (2018) "Cause of Cambrian explosion - Terrestrial or Cosmic?". Prog Biophys Mol Biol 2018; 136:27-28. [PMID: 29549026 DOI: 10.1016/j.pbiomolbio.2018.03.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Edward J Steele
- CY O'Connor ERADE Village Foundation, Piara Waters, WA, Australia; Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka.
| | - Shirwan Al-Mufti
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Kenneth A Augustyn
- Center for the Physics of Living Organisms, Department of Physics, Michigan Technological University, Michigan, United States
| | | | - John P Coghlan
- University of Melbourne, Office of the Dean, Faculty Medicine, Dentistry and Health Sciences, 3rd Level, Alan Gilbert Building, Australia
| | - S G Coulson
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Sudipto Ghosh
- Indian Institute of Technology Kharagpur and Bhaktivedanta Institute, Metallurgical & Materials Engineering IIT, Kanpur, India
| | - Mark Gillman
- South African Brain Research Institute, 6 Campbell Street, Waverly, Johannesburg, South Africa
| | - Reginald M Gorczynski
- University Toronto Health Network, Toronto General Hospital, University of Toronto, Canada
| | - Brig Klyce
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Godfrey Louis
- Department of Physics, Cochin University of Science and Technology Cochin, India
| | | | - Keith R Oliver
- School of Veterinary and Life Sciences Murdoch University, Perth, WA, Australia
| | - Julio Padron
- Studio Eutropi, Clinical Pathology and Nutrition, Via Pompei 46, Ardea 00040, Rome, Italy
| | - Jiangwen Qu
- Department of Infectious Disease Control, Tianjin Center for Disease Control and Prevention, China
| | - John A Schuster
- School of History and Philosophy of Science, Faculty of Science, University of Sydney, Sydney, Australia
| | - W E Smith
- Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Duane P Snyder
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Julian A Steele
- Centre for Surface Chemistry and Catalysis, KU Leuven, Celestijnenlaan 200F, 3001 Leuven, Belgium
| | - Brent J Stewart
- CY O'Connor ERADE Village Foundation, Piara Waters, WA, Australia
| | - Robert Temple
- The History of Chinese Culture Foundation, Conway Hall, London, UK
| | - Gensuke Tokoro
- Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Christopher A Tout
- Institute of Astronomy, The Observatories, Madingley Road, Cambridge CB3 0HA, UK
| | | | - Milton Wainwright
- Buckingham Centre for Astrobiology, University of Buckingham, UK; Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka
| | - Jamie Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Daryl H Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Max K Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - John Wetherall
- School of Biomedical Sciences, Perth, Curtin University, WA, Australia
| | - D T Wickramasinghe
- College of Physical and Mathematical Sciences, Australian National University, Canberra, Australia
| | | | - N Chandra Wickramasinghe
- Buckingham Centre for Astrobiology, University of Buckingham, UK; Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka; Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Yongsheng Liu
- Henan Collaborative Innovation Center of Modern Biological Breeding, Henan Institute of Science and Technology, Xinxiang, 453003, China; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada
| |
Collapse
|
8
|
Steele EJ, Al-Mufti S, Augustyn KA, Chandrajith R, Coghlan JP, Coulson SG, Ghosh S, Gillman M, Gorczynski RM, Klyce B, Louis G, Mahanama K, Oliver KR, Padron J, Qu J, Schuster JA, Smith WE, Snyder DP, Steele JA, Stewart BJ, Temple R, Tokoro G, Tout CA, Unzicker A, Wainwright M, Wallis J, Wallis DH, Wallis MK, Wetherall J, Wickramasinghe DT, Wickramasinghe JT, Wickramasinghe NC, Liu Y. Cause of Cambrian Explosion - Terrestrial or Cosmic? Prog Biophys Mol Biol 2018; 136:3-23. [PMID: 29544820 DOI: 10.1016/j.pbiomolbio.2018.03.004] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
We review the salient evidence consistent with or predicted by the Hoyle-Wickramasinghe (H-W) thesis of Cometary (Cosmic) Biology. Much of this physical and biological evidence is multifactorial. One particular focus are the recent studies which date the emergence of the complex retroviruses of vertebrate lines at or just before the Cambrian Explosion of ∼500 Ma. Such viruses are known to be plausibly associated with major evolutionary genomic processes. We believe this coincidence is not fortuitous but is consistent with a key prediction of H-W theory whereby major extinction-diversification evolutionary boundaries coincide with virus-bearing cometary-bolide bombardment events. A second focus is the remarkable evolution of intelligent complexity (Cephalopods) culminating in the emergence of the Octopus. A third focus concerns the micro-organism fossil evidence contained within meteorites as well as the detection in the upper atmosphere of apparent incoming life-bearing particles from space. In our view the totality of the multifactorial data and critical analyses assembled by Fred Hoyle, Chandra Wickramasinghe and their many colleagues since the 1960s leads to a very plausible conclusion - life may have been seeded here on Earth by life-bearing comets as soon as conditions on Earth allowed it to flourish (about or just before 4.1 Billion years ago); and living organisms such as space-resistant and space-hardy bacteria, viruses, more complex eukaryotic cells, fertilised ova and seeds have been continuously delivered ever since to Earth so being one important driver of further terrestrial evolution which has resulted in considerable genetic diversity and which has led to the emergence of mankind.
Collapse
Affiliation(s)
- Edward J Steele
- CY O'Connor ERADE Village Foundation, Piara Waters, WA, Australia; Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka.
| | - Shirwan Al-Mufti
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Kenneth A Augustyn
- Center for the Physics of Living Organisms, Department of Physics, Michigan Technological University, Michigan, United States
| | | | - John P Coghlan
- University of Melbourne, Office of the Dean, Faculty Medicine, Dentistry and Health Sciences, 3rd Level, Alan Gilbert Building, Australia
| | - S G Coulson
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Sudipto Ghosh
- Metallurgical & Materials Engineering IIT, Kanpur, India
| | - Mark Gillman
- South African Brain Research Institute, 6 Campbell Street, Waverly, Johannesburg, South Africa
| | - Reginald M Gorczynski
- University Toronto Health Network, Toronto General Hospital, University of Toronto, Canada
| | - Brig Klyce
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Godfrey Louis
- Department of Physics, Cochin University of Science and Technology Cochin, India
| | | | - Keith R Oliver
- School of Veterinary and Life Sciences Murdoch University, Perth, WA, Australia
| | - Julio Padron
- Studio Eutropi, Clinical Pathology and Nutrition, Via Pompei 46, Ardea, 00040, Rome, Italy
| | - Jiangwen Qu
- Department of Infectious Disease Control, Tianjin Center for Disease Control and Prevention, China
| | - John A Schuster
- School of History and Philosophy of Science, Faculty of Science, University of Sydney, Sydney, Australia
| | - W E Smith
- Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Duane P Snyder
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Julian A Steele
- Centre for Surface Chemistry and Catalysis, KU Leuven, Celestijnenlaan 200F, 3001, Leuven, Belgium
| | - Brent J Stewart
- CY O'Connor ERADE Village Foundation, Piara Waters, WA, Australia
| | - Robert Temple
- The History of Chinese Culture Foundation, Conway Hall, London, UK
| | - Gensuke Tokoro
- Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Christopher A Tout
- Institute of Astronomy, The Observatories, Madingley Road, Cambridge, CB3 0HA, UK
| | | | - Milton Wainwright
- Buckingham Centre for Astrobiology, University of Buckingham, UK; Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka
| | - Jamie Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Daryl H Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - Max K Wallis
- Buckingham Centre for Astrobiology, University of Buckingham, UK
| | - John Wetherall
- School of Biomedical Sciences, Perth, Curtin University, WA, Australia
| | - D T Wickramasinghe
- College of Physical and Mathematical Sciences, Australian National University, Canberra, Australia
| | | | - N Chandra Wickramasinghe
- Buckingham Centre for Astrobiology, University of Buckingham, UK; Centre for Astrobiology, University of Ruhuna, Matara, Sri Lanka; Institute for the Study of Panspermia and Astrobiology, Gifu, Japan
| | - Yongsheng Liu
- Henan Collaborative Innovation Center of Modern Biological Breeding, Henan Institute of Science and Technology, Xinxiang, 453003, China; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada
| |
Collapse
|
9
|
Zarate YA, Steinraths M, Matthews A, Smith WE, Sun A, Wilson LC, Brain C, Allgove J, Jacobs B, Fish JL, Powell CM, Wasserman WW, van Karnebeek CD, Wakeling EL, Ma NS. Bone health and SATB2-associated syndrome. Clin Genet 2017; 93:588-594. [PMID: 28787087 DOI: 10.1111/cge.13121] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Revised: 07/27/2017] [Accepted: 08/02/2017] [Indexed: 12/20/2022]
Abstract
SATB2-associated syndrome (SAS) is a rare disorder caused by alterations in the special AT-rich sequence-binding protein 2 (SATB2). Skeletal abnormalities such as tibial bowing, osteomalacia, osteopenia or osteoporosis have been reported suggesting a higher frequency of skeletal complications in SAS. The optimal timing, necessity, and methodology for routine assessment of bone health in individuals with SAS, however, remain unclear. We report molecular and phenotypic features of 7 individuals with SAS documented to have low bone mineral density (BMD) ascertained by dual-energy X-ray absorptiometry (DXA), often preceded by tibial bowing. The lowest BMD Z-scores ranged -2.3 to -5.6. In 4 individuals, total alkaline phosphatase levels were elevated (2 with elevated bone fraction) around the time of low BMD documentation. A clinically significant fracture history and a diagnosis of pediatric osteoporosis were present in 4 individuals. Pamidronate treatment in 2 children improved BMD. In conclusion, low BMD, fractures, and tibial bowing are relatively common skeletal complications in individuals with SAS. DXA is a useful tool when evaluating a child with SAS suspected to have low BMD and the results might alter clinical management.
Collapse
Affiliation(s)
- Y A Zarate
- Section of Genetics and Metabolism, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - M Steinraths
- Department of Medical Genetics, University of British Columbia, Vancouver, Canada
| | - A Matthews
- Department of Medical Genetics, University of British Columbia, Vancouver, Canada.,Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Vancouver, Canada
| | - W E Smith
- Department of Pediatrics, The Barbara Bush Children's Hospital, Maine Medical Center, Portland, Maine
| | - A Sun
- Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington
| | - L C Wilson
- Department of Genetics, Great Ormond Street for Children NHS Foundation Trust, London, UK
| | - C Brain
- Department of Endocrinology, Great Ormond Street for Children NHS Foundation Trust, London, UK
| | - J Allgove
- Department of Endocrinology, Great Ormond Street for Children NHS Foundation Trust, London, UK
| | - B Jacobs
- Department of Pediatrics, Royal National Orthopaedic Hospital NHS Trust, London, UK
| | - J L Fish
- Department of Biological Sciences, University of Massachusetts Lowell, Lowell, Massachusetts
| | - C M Powell
- Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.,Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
| | - W W Wasserman
- Department of Medical Genetics, University of British Columbia, Vancouver, Canada.,Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Vancouver, Canada
| | - C D van Karnebeek
- Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Vancouver, Canada.,Department of Pediatrics, University of British Columbia, Vancouver, Canada.,Department of Pediatrics and Clinical Genetics, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands
| | - E L Wakeling
- North West Thames Regional Genetics Service, London North West Healthcare NHS Trust, Harrow, UK
| | - N S Ma
- Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
| |
Collapse
|
10
|
Lee BH, Reijnders MRF, Abubakare O, Tuttle E, Lape B, Minks KQ, Stodgell C, Bennetto L, Kwon J, Fong CT, Gripp KW, Marsh ED, Smith WE, Huq AM, Coury SA, Tan WH, Solis O, Mehta RI, Leventer RJ, Baralle D, Hunt D, Paciorkowski AR. Expanding the neurodevelopmental phenotype of PURA syndrome. Am J Med Genet A 2017; 176:56-67. [PMID: 29150892 DOI: 10.1002/ajmg.a.38521] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2017] [Revised: 10/04/2017] [Accepted: 10/08/2017] [Indexed: 01/07/2023]
Abstract
PURA syndrome is a recently described developmental encephalopathy presenting with neonatal hypotonia, feeding difficulties, global developmental delay, severe intellectual disability, and frequent apnea and epilepsy. We describe 18 new individuals with heterozygous sequence variations in PURA. A neuromotor disorder starting with neonatal hyptonia, but ultimately allowing delayed progression to walking, was present in nearly all individuals. Congenital apnea was present in 56% during infancy, but all cases in this cohort resolved during the first year of life. Feeding difficulties were frequently reported, with gastrostomy tube placement required in 28%. Epilepsy was present in 50% of the subjects, including infantile spasms and Lennox-Gastaut syndrome. Skeletal complications were found in 39%. Disorders of gastrointestinal motility and nystagmus were also recurrent features. Autism was diagnosed in one individual, potentially expanding the neurodevelopmental phenotype associated with this syndrome. However, we did not find additional PURA sequence variations in a cohort of 120 subjects with autism. We also present the first neuropathologic studies of PURA syndrome, and describe chronic inflammatory changes around the arterioles within the deep white matter. We did not find significant correlations between mutational class and severity, nor between location of the sequence variation in PUR repeat domains. Further studies are required in larger cohorts of subjects with PURA syndrome to clarify these genotype-phenotype associations.
Collapse
Affiliation(s)
- Bo Hoon Lee
- Department of Neurology, University of Rochester Medical Center, Rochester, New York
| | - Margot R F Reijnders
- Department of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Oluwatobi Abubakare
- Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York
| | - Emily Tuttle
- Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York
| | - Brynn Lape
- Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York
| | - Kelly Q Minks
- Department of Neurology, University of Rochester Medical Center, Rochester, New York
| | - Christopher Stodgell
- Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York
| | - Loisa Bennetto
- Department of Clinical and Social Sciences in Psychology, University of Rochester, Rochester, New York
| | - Jennifer Kwon
- Department of Neurology, University of Rochester Medical Center, Rochester, New York.,Department of Pediatrics, University of Rochester Medical Center, Rochester, New York.,Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York
| | - Chin-To Fong
- Department of Pediatrics, University of Rochester Medical Center, Rochester, New York
| | - Karen W Gripp
- A.I. du Pont Hospital for Children/Nemours, Wilmington, Delaware
| | - Eric D Marsh
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, and Pediatric Regional Epilepsy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - Wendy E Smith
- Department of Pediatrics, Maine Medical Center, Portland, Maine
| | - Ahm M Huq
- Departments of Pediatrics and Neurology, Wayne State University, Children's Hospital of Michigan, Detroit, Michigan
| | - Stephanie A Coury
- Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts
| | - Wen-Hann Tan
- Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts
| | - Orestes Solis
- Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York
| | - Rupal I Mehta
- Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York.,Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York
| | - Richard J Leventer
- The Royal Children's Hospital Department of Neurology, University of Melbourne, Department of Pediatrics and the Murdoch Children's Hospital Institute, Melbourne, Victoria, Australia
| | - Diana Baralle
- Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.,Faculty of Medicine, Wessex Clinical Genetics Service, Princess Anne Hospital, University of Southampton, Southampton, Hampshire, UK
| | - David Hunt
- Faculty of Medicine, Wessex Clinical Genetics Service, Princess Anne Hospital, University of Southampton, Southampton, Hampshire, UK
| | - Alex R Paciorkowski
- Department of Neurology, University of Rochester Medical Center, Rochester, New York.,Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York.,Department of Pediatrics, University of Rochester Medical Center, Rochester, New York.,Departments of Neuroscience and Biomedical Genetics, University of Rochester Medical Center, Rochester, New York
| |
Collapse
|
11
|
Berry SA, Longo N, Diaz GA, McCandless SE, Smith WE, Harding CO, Zori R, Ficicioglu C, Lichter-Konecki U, Robinson B, Vockley J. Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years. Mol Genet Metab 2017; 122:46-53. [PMID: 28916119 DOI: 10.1016/j.ymgme.2017.09.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Revised: 09/01/2017] [Accepted: 09/01/2017] [Indexed: 12/30/2022]
Abstract
INTRODUCTION Glycerol phenylbutyrate (GPB) is approved in the US for the management of patients 2months of age and older with urea cycle disorders (UCDs) that cannot be managed with protein restriction and/or amino acid supplementation alone. Limited data exist on the use of nitrogen conjugation agents in very young patients. METHODS Seventeen patients (15 previously on other nitrogen scavengers) with all types of UCDs aged 2months to 2years were switched to, or started, GPB. Retrospective data up to 12months pre-switch and prospective data during initiation of therapy were used as baseline measures. The primary efficacy endpoint of the integrated analysis was the successful transition to GPB with controlled ammonia (<100μmol/L and no clinical symptoms). Secondary endpoints included glutamine and levels of other amino acids. Safety endpoints included adverse events, hyperammonemic crises (HACs), and growth and development. RESULTS 82% and 53% of patients completed 3 and 6months of therapy, respectively (mean 8.85months, range 6days-18.4months). Patients transitioned to GPB maintained excellent control of ammonia and glutamine levels. There were 36 HACs in 11 patients before GPB and 11 in 7 patients while on GPB, with a reduction from 2.98 to 0.88 episodes per year. Adverse events occurring in at least 10% of patients while on GPB were neutropenia, vomiting, diarrhea, pyrexia, hypophagia, cough, nasal congestion, rhinorrhea, rash/papule. CONCLUSION GPB was safe and effective in UCD patients aged 2months to 2years. GPB use was associated with good short- and long-term control of ammonia and glutamine levels, and the annualized frequency of hyperammonemic crises was lower during the study than before the study. There was no evidence for any previously unknown toxicity of GPB.
Collapse
Affiliation(s)
| | | | - George A Diaz
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Shawn E McCandless
- Center for Human Genetics, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, USA
| | | | | | | | - Can Ficicioglu
- Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | | | | | - Jerry Vockley
- Children's Hospital of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| |
Collapse
|
12
|
Kearns H, Sengupta S, Sasselli IR, Bromley Iii L, Faulds K, Tuttle T, Bedics MA, Detty MR, Velarde L, Graham D, Smith WE. Elucidation of the bonding of a near infrared dye to hollow gold nanospheres - a chalcogen tripod. Chem Sci 2016; 7:5160-5170. [PMID: 30155166 PMCID: PMC6020253 DOI: 10.1039/c6sc00068a] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Accepted: 04/19/2016] [Indexed: 12/15/2022] Open
Abstract
Determining how Raman labels orientate on the surface of HGNs to aid in future advancements of designing NIR nanosensors.
Infrared surface enhanced Raman scattering (SERS) is an attractive technique for the in situ detection of nanoprobes in biological samples due to the greater depth of penetration and reduced interference compared to SERS in the visible region. A key challenge is to understand the surface layer formed in suspension when a specific label is added to the SERS substrate in aqueous suspension. SERS taken at different wavelengths, theoretical calculations, and surface-selective sum frequency generation vibrational spectroscopy (SFG-VS) were used to define the surface orientation and manner of attachment of a new class of infrared SERS labels with a thiopyrylium core and four pendant 2-selenophenyl rings. Hollow gold nanospheres (HGNs) were used as the enhancing substrate and two distinct types of SERS spectra were obtained. With excitation close to resonance with both the near infrared electronic transition in the label (max 826 nm) and the plasmon resonance maximum (690 nm), surface enhanced resonance Raman scattering (SERRS) was obtained. SERRS indicates that the major axis of the core is near to perpendicular to the surface plane and SFG-VS obtained from a dried gold film gave a similar orientation with the major axis at an angle 64–85° from the surface plane. Longer excitation wavelengths give SERS with little or no molecular resonance contribution and new vibrations appeared with significant displacements between the thiopyrylium core and the pendant selenophene rings. Analysis using calculated spectra with one or two rings rotated indicates that two rings on one end are rotated towards the metal surface to give an arrangement of two selenium and one sulphur atoms directly facing the gold structure. The spectra, together with a space filled model, indicate that the molecule is strongly adsorbed to the surface through the selenium and sulphur atoms in an arrangement which will facilitate layer formation.
Collapse
Affiliation(s)
- H Kearns
- Department of Pure and Applied Chemistry , Technology and Innovation Centre , University of Strathclyde , 99 George Street , Glasgow G1 1RD , UK .
| | - S Sengupta
- Department of Chemistry , University at Buffalo , Buffalo , NY 14260 , USA .
| | - I Ramos Sasselli
- Department of Pure and Applied Chemistry , Technology and Innovation Centre , University of Strathclyde , 99 George Street , Glasgow G1 1RD , UK .
| | - L Bromley Iii
- Department of Chemistry , University at Buffalo , Buffalo , NY 14260 , USA .
| | - K Faulds
- Department of Pure and Applied Chemistry , Technology and Innovation Centre , University of Strathclyde , 99 George Street , Glasgow G1 1RD , UK .
| | - T Tuttle
- Department of Pure and Applied Chemistry , Technology and Innovation Centre , University of Strathclyde , 99 George Street , Glasgow G1 1RD , UK .
| | - M A Bedics
- Department of Chemistry , University at Buffalo , Buffalo , NY 14260 , USA .
| | - M R Detty
- Department of Chemistry , University at Buffalo , Buffalo , NY 14260 , USA .
| | - L Velarde
- Department of Chemistry , University at Buffalo , Buffalo , NY 14260 , USA .
| | - D Graham
- Department of Pure and Applied Chemistry , Technology and Innovation Centre , University of Strathclyde , 99 George Street , Glasgow G1 1RD , UK .
| | - W E Smith
- Department of Pure and Applied Chemistry , Technology and Innovation Centre , University of Strathclyde , 99 George Street , Glasgow G1 1RD , UK .
| |
Collapse
|
13
|
Gracie K, Smith WE, Yip P, Sutter JU, Birch DJS, Graham D, Faulds K. Interaction of fluorescent dyes with DNA and spermine using fluorescence spectroscopy. Analyst 2015; 139:3735-43. [PMID: 24915043 DOI: 10.1039/c4an00680a] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Oligonucleotides labelled with fluorescent dyes are widely used as probes for the identification of DNA sequences in detection methods using optical spectroscopies such as fluorescence and surface enhanced Raman scattering (SERS). Spermine is widely used in surface enhanced based assays as a charge reduction and aggregating agent as it interacts strongly with the phosphate backbone and has shown to enhance the signal of a labelled oligonucleotide. The fluorescence intensity of two commonly used labels, FAM and TAMRA, were compared when spermine was added under different experimental conditions. There was a marked difference upon conjugating the free dye to an oligonucleotide, when FAM was conjugated to an oligonucleotide there was around a six fold decrease in emission, compared to a six fold increase when TAMRA was conjugated to an oligonucleotide. Dye labelled single and double stranded DNA also behaved differently with double stranded DNA labelled with FAM being a much more efficient emitter in the mid pH range, however TAMRA becomes increasingly less efficient as the pH rises. Upon addition of the base spermine, signal enhancement from the FAM labelled oligonucleotide is observed. Increasing probe concentrations of TAMRA oligonucleotide above 0.5 μM led to signal reduction most likely through quenching, either by an interaction with guanine, or through self-quenching. By using different bases for comparison, spermine and triethylamine (TEA), different affects were observed in the measured fluorescence signals. When TEA was added to FAM, a reduction in the pH dependence of fluorescence was observed, which may be useful for mid pH range assays. With the drive to increase information content and decrease time and complexity of DNA assays it is likely that more assays will be carried out in complex media such as extracted DNA fragments and PCR product. This model study indicates that dye DNA and dye spermine interactions are dye specific and that extreme care with conditions is necessary particularly if it is intended to determine the concentrations of multiple analytes using probes labelled with different dyes.
Collapse
Affiliation(s)
- K Gracie
- Centre of Molecular Nanometrology, WestChem, Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK.
| | | | | | | | | | | | | |
Collapse
|
14
|
Smith WE, Kwak TJ. Otolith microchemistry of tropical diadromous fishes: spatial and migratory dynamics. J Fish Biol 2014; 84:913-928. [PMID: 24673161 DOI: 10.1111/jfb.12317] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2013] [Accepted: 11/28/2013] [Indexed: 06/03/2023]
Abstract
Otolith microchemistry was applied to quantify migratory variation and the proportion of native Caribbean stream fishes that undergo full or partial marine migration. Strontium and barium water chemistry in four Puerto Rico, U.S.A., rivers was clearly related to a salinity gradient; however, variation in water barium, and thus fish otoliths, was also dependent on river basin. Strontium was the most accurate index of longitudinal migration in tropical diadromous fish otoliths. Among the four species examined, bigmouth sleeper Gobiomorus dormitor, mountain mullet Agonostomus monticola, sirajo goby Sicydium spp. and river goby Awaous banana, most individuals were fully amphidromous, but 9-12% were semi-amphidromous as recruits, having never experienced marine or estuarine conditions in early life stages and showing no evidence of marine elemental signatures in their otolith core. Populations of one species, G. dormitor, may have contained a small contingent of semi-amphidromous adults, migratory individuals that periodically occupied marine or estuarine habitats (4%); however, adult migratory elemental signatures may have been confounded with those related to diet and physiology. These findings indicate the plasticity of migratory strategies of tropical diadromous fishes, which may be more variable than simple categorization might suggest.
Collapse
Affiliation(s)
- W E Smith
- North Carolina Cooperative Fish and Wildlife Research Unit, Department of Applied Ecology, Campus Box 7617, North Carolina State University, Raleigh, NC 27695, U.S.A
| | | |
Collapse
|
15
|
Abstract
Adult movement scale was quantified for two tropical Caribbean diadromous fishes, bigmouth sleeper Gobiomorus dormitor and mountain mullet Agonostomus monticola, using passive integrated transponders (PITs) and radio-telemetry. Large numbers of fishes were tagged in Río Mameyes, Puerto Rico, U.S.A., with PITs and monitored at three fixed locations over a 2·5 year period to estimate transition probabilities between upper and lower elevations and survival probabilities with a multistate Cormack-Jolly-Seber model. A sub-set of fishes were tagged with radio-transmitters and tracked at weekly intervals to estimate fine-scale dispersal. Changes in spatial and temporal distributions of tagged fishes indicated that neither G. dormitor nor A. monticola moved into the lowest, estuarine reaches of Río Mameyes during two consecutive reproductive periods, thus demonstrating that both species follow an amphidromous, rather than catadromous, migratory strategy. Further, both species were relatively sedentary, with restricted linear ranges. While substantial dispersal of these species occurs at the larval stage during recruitment to fresh water, the results indicate minimal dispersal in spawning adults. Successful conservation of diadromous fauna on tropical islands requires management at both broad basin and localized spatial scales.
Collapse
Affiliation(s)
- W E Smith
- North Carolina Cooperative Fish and Wildlife Research Unit, Department of Applied Ecology, Campus Box 7617, North Carolina State University, Raleigh, NC 27695, U.S.A
| | | |
Collapse
|
16
|
Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 2014; 16:188-200. [PMID: 24385074 DOI: 10.1038/gim.2013.157] [Citation(s) in RCA: 380] [Impact Index Per Article: 38.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2013] [Accepted: 08/29/2013] [Indexed: 11/08/2022] Open
Abstract
Phenylalanine hydroxylase deficiency, traditionally known as phenylketonuria, results in the accumulation of phenylalanine in the blood of affected individuals and was the first inborn error of metabolism to be identified through population screening. Early identification and treatment prevent the most dramatic clinical sequelae of the disorder, but new neurodevelopmental and psychological problems have emerged in individuals treated from birth. The additional unanticipated recognition of a toxic effect of elevated maternal phenylalanine on fetal development has added to a general call in the field for treatment for life. Two major conferences sponsored by the National Institutes of Health held >10 years apart reviewed the state of knowledge in the field of phenylalanine hydroxylase deficiency, but there are no generally accepted recommendations for therapy. The purpose of this guideline is to review the strength of the medical literature relative to the treatment of phenylalanine hydroxylase deficiency and to develop recommendations for diagnosis and therapy of this disorder. Evidence review from the original National Institutes of Health consensus conference and a recent update by the Agency for Healthcare Research and Quality was used to address key questions in the diagnosis and treatment of phenylalanine hydroxylase deficiency by a working group established by the American College of Medical Genetics and Genomics. The group met by phone and in person over the course of a year to review these reports, develop recommendations, and identify key gaps in our knowledge of this disorder. Above all, treatment of phenylalanine hydroxylase deficiency must be life long, with a goal of maintaining blood phenylalanine in the range of 120-360 µmol/l. Treatment has predominantly been dietary manipulation, and use of low protein and phenylalanine medical foods is likely to remain a major component of therapy for the immediate future. Pharmacotherapy for phenylalanine hydroxylase deficiency is in early stages with one approved medication (sapropterin, a derivative of the natural cofactor of phenylalanine hydroxylase) and others under development. Eventually, treatment of phenylalanine hydroxylase deficiency will be individualized with multiple medications and alternative medical foods available to tailor therapy. The primary goal of therapy should be to lower blood phenylalanine, and any interventions, including medications, or combination of therapies that help to achieve that goal in an individual, without other negative consequences, should be considered appropriate therapy. Significant evidence gaps remain in our understanding of the optimum therapies for phenylalanine hydroxylase deficiency, nonphenylalanine effects of these therapies, and long-term sequelae of even well-treated disease in children and adults.
Collapse
Affiliation(s)
- Jerry Vockley
- 1] Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA [2] Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA
| | - Hans C Andersson
- Hayward Genetics Center, Tulane University Medical School, New Orleans, Louisiana, USA
| | - Kevin M Antshel
- Department of Psychology, Syracuse University, Syracuse, New York, USA
| | - Nancy E Braverman
- Department of Human Genetics and Pediatrics, McGill University, Montreal, Quebec, Canada
| | - Barbara K Burton
- Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA
| | - Dianne M Frazier
- Department of Pediatrics, University of North Carolina, at Chapel Hill, Chapel Hill, North Carolina, USA
| | - John Mitchell
- Department of Human Genetics and Pediatrics, McGill University, Montreal, Quebec, Canada
| | - Wendy E Smith
- Department of Pediatrics, Maine Medical Center, Portland, Maine, USA1
| | - Barry H Thompson
- The American College of Medical Genetics and Genomics, Bethesda, Maryland, USA
| | - Susan A Berry
- Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA
| |
Collapse
|
17
|
Abstract
Accurate multiplex genotyping of the mutational status of the cystic fibrosis gene with the sensitive and selective SERRS technique is reported. This new assay does not require separation of the various alleles and shows that SERRS is a realistic alternative detection technique for use in modern DNA assays.
Collapse
Affiliation(s)
- D Graham
- Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK.
| | | | | | | |
Collapse
|
18
|
Barber JCK, Rosenfeld JA, Foulds N, Laird S, Bateman MS, Thomas NS, Baker S, Maloney VK, Anilkumar A, Smith WE, Banks V, Ellingwood S, Kharbutli Y, Mehta L, Eddleman KA, Marble M, Zambrano R, Crolla JA, Lamb AN. 8p23.1 duplication syndrome; common, confirmed, and novel features in six further patients. Am J Med Genet A 2013; 161A:487-500. [PMID: 23345203 DOI: 10.1002/ajmg.a.35767] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2012] [Accepted: 10/14/2012] [Indexed: 01/07/2023]
Abstract
The 8p23.1 duplication syndrome is a relatively rare genomic condition that has been confirmed with molecular cytogenetic methods in only 11 probands and five family members. Here, we describe another prenatal and five postnatal patients with de novo 8p23.1 duplications analyzed with oligonucleotide array comparative genomic hybridization (oaCGH). Of the common features, mild or moderate developmental delays and/or learning difficulties have been found in 11/12 postnatal probands, a variable degree of mild dysmorphism in 8/12 and congenital heart disease (CHD) in 4/5 prenatal and 3/12 postnatal probands. Behavioral problems, cleft lip and/or palate, macrocephaly, and seizures were confirmed as additional features among the new patients, and novel features included neonatal respiratory distress, attention deficit hyperactivity disorder (ADHD), ocular anomalies, balance problems, hypotonia, and hydrocele. The core duplication of 3.68 Mb contains 31 genes and microRNAs of which only GATA4, TNKS, SOX7, and XKR6 are likely to be dosage sensitive genes and MIR124-1 and MIR598 have been implicated in neurocognitive phenotypes. A combination of the duplication of GATA4, SOX7, and related genes may account for the variable penetrance of CHD. Two of the duplications were maternal and intrachromosomal in origin with maternal heterozygosity for the common inversion between the repeats in 8p23.1. These additional patients and the absence of the 8p23.1 duplications in published controls, indicate that the 8p23.1 duplication syndrome may now be considered a pathogenic copy number variation (pCNV) with an estimated population prevalence of 1 in 58,000.
Collapse
Affiliation(s)
- John C K Barber
- Faculty of Medicine, Department of Human Genetics and Genomic Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Nitschke Y, Baujat G, Botschen U, Wittkampf T, du Moulin M, Stella J, Le Merrer M, Guest G, Lambot K, Tazarourte-Pinturier MF, Chassaing N, Roche O, Feenstra I, Loechner K, Deshpande C, Garber SJ, Chikarmane R, Steinmann B, Shahinyan T, Martorell L, Davies J, Smith WE, Kahler SG, McCulloch M, Wraige E, Loidi L, Höhne W, Martin L, Hadj-Rabia S, Terkeltaub R, Rutsch F. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 2012; 90:25-39. [PMID: 22209248 DOI: 10.1016/j.ajhg.2011.11.020] [Citation(s) in RCA: 229] [Impact Index Per Article: 19.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2011] [Revised: 10/29/2011] [Accepted: 11/21/2011] [Indexed: 12/20/2022] Open
Abstract
Spontaneous pathologic arterial calcifications in childhood can occur in generalized arterial calcification of infancy (GACI) or in pseudoxanthoma elasticum (PXE). GACI is associated with biallelic mutations in ENPP1 in the majority of cases, whereas mutations in ABCC6 are known to cause PXE. However, the genetic basis in subsets of both disease phenotypes remains elusive. We hypothesized that GACI and PXE are in a closely related spectrum of disease. We used a standardized questionnaire to retrospectively evaluate the phenotype of 92 probands with a clinical history of GACI. We obtained the ENPP1 genotype by conventional sequencing. In those patients with less than two disease-causing ENPP1 mutations, we sequenced ABCC6. We observed that three GACI patients who carried biallelic ENPP1 mutations developed typical signs of PXE between 5 and 8 years of age; these signs included angioid streaks and pseudoxanthomatous skin lesions. In 28 patients, no disease-causing ENPP1 mutation was found. In 14 of these patients, we detected pathogenic ABCC6 mutations (biallelic mutations in eight patients, monoallelic mutations in six patients). Thus, ABCC6 mutations account for a significant subset of GACI patients, and ENPP1 mutations can also be associated with PXE lesions in school-aged children. Based on the considerable overlap of genotype and phenotype of GACI and PXE, both entities appear to reflect two ends of a clinical spectrum of ectopic calcification and other organ pathologies, rather than two distinct disorders. ABCC6 and ENPP1 mutations might lead to alterations of the same physiological pathways in tissues beyond the artery.
Collapse
Affiliation(s)
- Yvonne Nitschke
- Department of General Pediatrics, Münster University Children's Hospital, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Stankiewicz P, Kulkarni S, Dharmadhikari AV, Sampath S, Bhatt SS, Shaikh TH, Xia Z, Pursley AN, Cooper ML, Shinawi M, Paciorkowski AR, Grange DK, Noetzel MJ, Saunders S, Simons P, Summar M, Lee B, Scaglia F, Fellmann F, Martinet D, Beckmann JS, Asamoah A, Platky K, Sparks S, Martin AS, Madan-Khetarpal S, Hoover J, Medne L, Bonnemann CG, Moeschler JB, Vallee SE, Parikh S, Irwin P, Dalzell VP, Smith WE, Banks VC, Flannery DB, Lovell CM, Bellus GA, Golden-Grant K, Gorski JL, Kussmann JL, McGregor TL, Hamid R, Pfotenhauer J, Ballif BC, Shaw CA, Kang SHL, Bacino CA, Patel A, Rosenfeld JA, Cheung SW, Shaffer LG. Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat 2011; 33:165-79. [PMID: 21948486 DOI: 10.1002/humu.21614] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2011] [Accepted: 09/06/2011] [Indexed: 11/11/2022]
Abstract
We report 24 unrelated individuals with deletions and 17 additional cases with duplications at 10q11.21q21.1 identified by chromosomal microarray analysis. The rearrangements range in size from 0.3 to 12 Mb. Nineteen of the deletions and eight duplications are flanked by large, directly oriented segmental duplications of >98% sequence identity, suggesting that nonallelic homologous recombination (NAHR) caused these genomic rearrangements. Nine individuals with deletions and five with duplications have additional copy number changes. Detailed clinical evaluation of 20 patients with deletions revealed variable clinical features, with developmental delay (DD) and/or intellectual disability (ID) as the only features common to a majority of individuals. We suggest that some of the other features present in more than one patient with deletion, including hypotonia, sleep apnea, chronic constipation, gastroesophageal and vesicoureteral refluxes, epilepsy, ataxia, dysphagia, nystagmus, and ptosis may result from deletion of the CHAT gene, encoding choline acetyltransferase, and the SLC18A3 gene, mapping in the first intron of CHAT and encoding vesicular acetylcholine transporter. The phenotypic diversity and presence of the deletion in apparently normal carrier parents suggest that subjects carrying 10q11.21q11.23 deletions may exhibit variable phenotypic expressivity and incomplete penetrance influenced by additional genetic and nongenetic modifiers.
Collapse
Affiliation(s)
- Paweł Stankiewicz
- Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Abstract
Neurodevelopmental disorders with identified genetic etiologies present a unique opportunity to study gene-brain-behavior connections in child psychiatry. Parsing complex human behavior into dissociable components is facilitated by examining a relatively homogenous genetic population. As children with developmental delay carry a greater burden of mental illness than the general population, familiarity with the most common genetic disorders will serve practitioners seeing a general child population. In this article, basic genetic testing and 11 of the most common genetic disorders are reviewed, including the evidence base for treatment. Based on their training in child development, family systems, and multimodal treatment, child psychiatrists are well positioned to integrate cognitive, behavioral, social, psychiatric, and physical phenotypes, with a focus on functional impairment.
Collapse
Affiliation(s)
- Matthew S Siegel
- Department of Psychiatry, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02110, USA.
| | | |
Collapse
|
22
|
Burkardt DD, Rosenfeld JA, Helgeson ML, Angle B, Banks V, Smith WE, Gripp KW, Moline J, Moran RT, Niyazov DM, Stevens CA, Zackai E, Lebel RR, Ashley DG, Kramer N, Lachman RS, Graham JM. Distinctive phenotype in 9 patients with deletion of chromosome 1q24-q25. Am J Med Genet A 2011; 155A:1336-51. [PMID: 21548129 DOI: 10.1002/ajmg.a.34049] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2010] [Accepted: 03/20/2011] [Indexed: 11/08/2022]
Abstract
Reports of individuals with deletions of 1q24→q25 share common features of prenatal onset growth deficiency, microcephaly, small hands and feet, dysmorphic face and severe cognitive deficits. We report nine individuals with 1q24q25 deletions, who show distinctive features of a clinically recognizable 1q24q25 microdeletion syndrome: prenatal-onset microcephaly and proportionate growth deficiency, severe cognitive disability, small hands and feet with distinctive brachydactyly, single transverse palmar flexion creases, fifth finger clinodactyly and distinctive facial features: upper eyelid fullness, small ears, short nose with bulbous nasal tip, tented upper lip, and micrognathia. Radiographs demonstrate disharmonic osseous maturation with markedly delayed bone age. Occasional features include cleft lip and/or palate, cryptorchidism, brain and spinal cord defects, and seizures. Using oligonucleotide-based array comparative genomic hybridization, we defined the critical deletion region as 1.9 Mb at 1q24.3q25.1 (chr1: 170,135,865-172,099,327, hg18 coordinates), containing 13 genes and including CENPL, which encodes centromeric protein L, a protein essential for proper kinetochore function and mitotic progression. The growth deficiency in this syndrome is similar to what is seen in other types of primordial short stature with microcephaly, such as Majewski osteodysplastic primordial dwarfism, type II (MOPD2) and Seckel syndrome, which result from loss-of-function mutations in genes coding for centrosomal proteins. DNM3 is also in the deleted region and expressed in the brain, where it participates in the Shank-Homer complex and increases synaptic strength. Therefore, DNM3 is a candidate for the cognitive disability, and CENPL is a candidate for growth deficiency in this 1q24q25 microdeletion syndrome.
Collapse
|
23
|
Chen G, Wilson R, Cumming G, Smith WE, Fraser WD, Walker JJ, Mckillop JH. Effects of Atenolol, Labetalol and Methyldopa on Endogenous Antioxidants In-vitro. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1995.tb05731.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Abstract
The aim of this study was to investigate whether atenolol, labetalol and methyldopa, which are commonly used for the treatment of hypertension in pregnancy, can induce antioxidant activity.
Reactive oxygen species scavengers (plasma thiol, red cell lysate thiol, red cell superoxide dismutase, red cell membrane thiol and plasma glutathione) were measured after incubation of peripheral blood with atenolol and methyldopa, respectively.
The results showed that atenolol and labetalol could significantly raise the levels of plasma thiol and membrane thiol but had no effects on lysate thiol, superoxide dismutase and glutathione. The effects on membrane thiol occurred after 60 min incubation and on plasma thiol after 120 min incubation.
The data also suggest that atenolol and labetalol at lower concentrations tend to have additive effects on reactive oxygen species scavengers but at higher concentrations do not.
Methyldopa had no significant effect on any of the parameters measured.
These findings suggest that atenolol and labetalol are able to induce higher levels of antioxidant activity.
Collapse
Affiliation(s)
- G Chen
- University of Glasgow, Department of Medicine, 10 Alexandra Parade, Glasgow G31 2ER
| | - R Wilson
- University of Glasgow, Department of Medicine, 10 Alexandra Parade, Glasgow G31 2ER
| | - G Cumming
- Department of Obstetrics, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER
| | - W E Smith
- Department of Chemistry, University of Strathclyde, Glasgow G1 1XQ
| | - W D Fraser
- Department of Clinical Chemistry, Royal Liverpool University Hospital, Liverpool L69 3BX, UK
| | - J J Walker
- Department of Obstetrics, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER
| | - J H Mckillop
- University of Glasgow, Department of Medicine, 10 Alexandra Parade, Glasgow G31 2ER
| |
Collapse
|
24
|
|
25
|
Rosenfeld JA, Stephens LE, Coppinger J, Ballif BC, Hoo JJ, French BN, Banks VC, Smith WE, Manchester D, Tsai ACH, Merrion K, Mendoza-Londono R, Dupuis L, Schultz R, Torchia B, Sahoo T, Bejjani B, Weaver DD, Shaffer LG. Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes. Eur J Hum Genet 2011; 19:547-54. [PMID: 21248749 DOI: 10.1038/ejhg.2010.237] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
Non-allelic homologous recombination (NAHR) between segmental duplications in proximal chromosome 15q breakpoint (BP) regions can lead to microdeletions and microduplications. Several individuals with deletions flanked by BP3 and BP4 on 15q13, immediately distal to, and not including the Prader-Willi/Angelman syndrome (PW/AS) critical region and proximal to the BP4-BP5 15q13.3 microdeletion syndrome region, have been reported; however, because the deletion has also been found in normal relatives, the significance of these alterations is unclear. We have identified six individuals with deletions limited to the BP3-BP4 interval and an additional four individuals with deletions of the BP3-BP5 interval from 34 046 samples submitted for clinical testing by microarray-based comparative genomic hybridization (aCGH). Of four individuals with BP3-BP4 deletions for whom parental testing was conducted, two were apparently de novo and two were maternally inherited. A comparison of clinical features, available for five individuals in our study (four with deletions within BP3-BP4 and one with a BP3-BP5 deletion), with those in the literature show common features of short stature and/or failure to thrive, microcephaly, hypotonia, and premature breast development in some individuals. Although the BP3-BP4 deletion does not yet demonstrate statistically significant enrichment in abnormal populations compared with control populations, the presence of common clinical features among probands and the presence of genes with roles in development and nervous system function in the deletion region suggest that this deletion may have a role in abnormal phenotypes in some individuals.
Collapse
|
26
|
Abstract
Epithelial tumors have been readily obtained by the implantation of embryo stomach tissue together with olive oil containing methylcholanthrene (with or without Scharlach R) in adult mice of homologous strain. The implanted tissue from the squamous portion of the stomach rapidly encysted the oil, and benign and malignant papillomas and squamous cell carcinomas soon arose from the stratified squamous lining of the cysts. Bits of the glandular portion of the stomach also formed cysts, but the gland cells underwent metaplasia in response to the carcinogen, altering first to transitional epithelium and then to a stratified squamous layer. So swiftly did these changes take place that nearly all of the tumors took origin from epithelium that had already become stratified and squamous, and the growths themselves were of this type. A single transitional cell carcinoma and an adenoacanthoma were procured, but no adenocarcinomas; nor did any benign papillomas develop, though they often resulted from the action of methylcholanthrene on the squamous portion of the embryo stomach. Search failed to disclose any distinctive precancerous changes in the gastric tissue. Five of the cancers were transplanted and they grew in every host. No tumors arose from any of the numerous control implants. Those consisting of glandular tissue formed cysts lined partly with columnar epithelium secreting mucus and partly with tubular glands equipped with chief and parietal cells in good condition. Pepsin and rennin were found in the fluid contained in these cysts, but no free hydrochloric acid. The enzymes were present also when the cysts contained methylcholanthrene and the glands had not yet been wholly replaced by metaplastic epithelium. The tumors appeared months sooner than when methylcholanthrene is injected into the stomach of adult animals or given by mouth; some of them were well established after 5 or 6 weeks. They arose regularly when the requisite experimental conditions were provided. The utilization of transplanted embryo tissue provides a means whereby gastric tumors free from bacterial infection can be procured swiftly and easily.
Collapse
Affiliation(s)
- W E Smith
- Laboratories of The Rockefeller Institute for Medical Research
| |
Collapse
|
27
|
Rous P, Smith WE. THE NEOPLASTIC POTENTIALITIES OF MOUSE EMBRYO TISSUES : I. THE FINDINGS WITH SKIN OF C STRAIN EMBRYOS TRANSPLANTED TO ADULT ANIMALS. ACTA ACUST UNITED AC 2010; 81:597-620. [PMID: 19871479 PMCID: PMC2135522 DOI: 10.1084/jem.81.6.597] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
A method has been devised whereby the transplanted epidermis of mouse embryos can be selectively exposed to the action of a chemical carcinogen. Scharlach R was dissolved in olive oil with the aim of stimulating and attracting the epidermal cells, methylcholanthrene was added to the solution, and numerous fine globules of it were injected into the thigh muscles of adult mice together with fragments of embryo skin. Much of the oil underwent primary inclusion in the resulting cysts, and the proliferating epidermis, while forming them, extended to not a few of the outlying droplets with result that they too were added to the cyst contents. During these activities the methylcholanthrene came into direct contact with many of the epithelial cells, and later on the layer lining the cyst was continually exposed to the influence of the carcinogen. The epidermis underwent neoplastic changes with great rapidity; often in less than 4 weeks papillomas and carcinomas had arisen like those deriving from adult epidermis. The growths were punctate in origin and usually multiple. Many were transplanted to adults of the same homologous breed of mice that furnished the embryo material (mice of C strain). The grafts did not uniformly succeed as was the case with those of normal skin of embryos of the same stock,-which regularly grew at first in the new hosts and remained alive long after. The benign papillomas failed to live or barely survived, and the apparently malignant papillomas, though rapidly forming nodules of considerable size, usually regressed later. Some of the carcinomas also regressed or wholly failed, while others gave rise to progressively enlarging tumors. The best results were obtained with grafts in which several neoplasms were intermingled, these flourishing together in the new hosts. Methylcholanthrene in olive oil exerts an influence on epidermal cells like that of Scharlach R, stimulating them to multiply, attracting them, and causing them to mimic carcinomatous elements.
Collapse
Affiliation(s)
- P Rous
- Laboratories of The Rockefeller Institute for Medical Research
| | | |
Collapse
|
28
|
Smith WE, Rous P. THE NEOPLASTIC POTENTIALITIES OF MOUSE EMBRYO TISSUES : II. CONTRIBUTORY EXPERIMENTS; RESULTS WITH THE SKIN OF C3H AND WEBSTER-SWISS EMBRYOS; GENERAL CONSIDERATIONS. ACTA ACUST UNITED AC 2010; 81:621-46. [PMID: 19871480 PMCID: PMC2135521 DOI: 10.1084/jem.81.6.621] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Experiments were carried out to learn whether the widely differing liabilities to induced epidermal tumors of individual mice and rabbits are due to a previous localization out of the blood of an agent capable of undergoing change when the skin is exposed to carcinogenic influences, and of producing tumors in consequence. On the assumption that such an agent would localize in increased quantity where cutaneous inflammation exists, like various inert substances of large molecule and the epidermotrophic viruses when circulating, skin areas on adult and new-born animals were for some weeks kept inflamed, and months later, when the areas appeared normal, methylcholanthrene was applied to them and to control areas on the same or other individuals. No differences were observable in tumor incidence. These results led to attempts to test whether embryo epidermis is capable of undergoing neoplastic change, and the work of Paper I was done which showed that epidermal tumors arise with great rapidity and regularity from embryo skin transplanted to adults of homologous strain (C strain) together with methylcholanthrene. Webster-Swiss mice proved unsuited to experiments of the sort owing to heterogeneity of the breed, the transplanted embryo skin dying in most instances before the methylcholanthrene introduced with it could have been carcinogenic. The skin of C3H embryos also did badly, as if from incompatibility in some instances but mostly because its epidermal cells proliferated less vigorously than those of C embryos and did not tolerate methylcholanthrene nearly so well. Despite these difficulties, epidermal tumors were occasionally induced, as also in the transplanted skin of Webster-Swiss embryos, and the growths appeared quite soon, all things considered. The effect of methylcholanthrene on the skin of sucklings, their mothers, and young adult mice of the C strain was studied in order to find out whether the rapid rate of neoplastic change in the transplanted epidermis of embryos is indicative of some liability connected with its period of development. The skin of new-born animals proved very refractory to the carcinogen, hair coming in at the same rate as on control litters and no perceptible inflammation occurring for about 2 weeks, although within this period the mothers of the treated animals and the young adults became hairless where the methylcholanthrene had been put and their skin was much inflamed. Later on, as the applications were kept up, similar changes took place in the sucklings, but none of these developed tumors during some 6 weeks of observation whereas growths appeared within 3 weeks on more than half of the mother mice and on some of the young adults. The failure to produce tumors in the sucklings seems to have been due to cutaneous conditions preventing the necessary exposure of the deeper epidermal cells to methylcholanthrene. In any projected correlation of age differences with the response of cells to carcinogens allowance must be made for such factors. The present findings give no ground for the supposition that embryo skin has any special liability to neoplastic change. The results of transferring the tumors derived from embryo epidermis to new hosts have made plain that the neoplastic state not infrequently entails disabilities which are crucial, the tumor cells failing to succeed unless aided. This holds true of some carcinomas as well as of papillomas. By transplanting pieces of the organs of C embryos together with methylcholanthrene tumors of many sorts besides the epidermal have been obtained. As yet only those of the stomach have been worked with extensively. They can be elicited as quickly and regularly as those of the epidermis and can be as easily transplanted. The findings as a whole render it impossible to suppose that the neoplastic potentialities possessed by transplanted embryo tissues are due to the lodgement in them of tumor-producing viruses as specialized in their effects as those now known, or of precursor agents conferring neoplastic liabilities specialized to the same degree. Some other possibilities are mentioned. The rarity of neoplasms at birth is due to the circumstances of intrauterine life and to its brevity, not to any lack of capacity of the cells of the embryo to undergo neoplastic change.
Collapse
Affiliation(s)
- W E Smith
- Laboratories of The Rockefeller Institute for Medical Research
| | | |
Collapse
|
29
|
Abstract
Neurodevelopmental disorders with identified genetic etiologies present a unique opportunity to study gene-brain-behavior connections in child psychiatry. Parsing complex human behavior into dissociable components is facilitated by examining a relatively homogenous genetic population. As children with developmental delay carry a greater burden of mental illness than the general population, familiarity with the most common genetic disorders will serve practitioners seeing a general child population. In this article basic genetic testing and 11 of the most common genetic disorders are reviewed, including the evidence base for treatment. Based on their training in child development, family systems, and multimodal treatment, child psychiatrists are well positioned to integrate cognitive, behavioral, social, psychiatric, and physical phenotypes, with a focus on functional impairment.
Collapse
Affiliation(s)
- Matthew S Siegel
- Department of Psychiatry, Tufts University School of Medicine, Boston, MA 02110, USA.
| | | |
Collapse
|
30
|
Smith WE, Sullivan-Saarela JA, Li JS, Cox GF, Corzo D, Chen YT, Kishnani PS. Sibling phenotype concordance in classical infantile Pompe disease. Am J Med Genet A 2008; 143A:2493-501. [PMID: 17853454 DOI: 10.1002/ajmg.a.31936] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Pompe disease (acid-alpha-glucosidase deficiency) encompasses a clinical spectrum, ranging from severe infantile-onset disease with clinical symptoms appearing before 1 year of age with rapid progression to an early death, to late-onset disease with a much more variable age at onset and disease course. Sibling phenotype discordance has been reported for late-onset Pompe disease, but has not been studied in classical infantile disease. We reviewed the medical literature for affected sibships in which at least one sibling had clinical and pathology or biochemical findings consistent with infantile Pompe disease including symptoms beginning in infancy, early hypotonia, cardiomegaly documented by 6 months of age, and early death. The age at symptom onset, age at death, and clinical course were compared between probands and affected siblings. Our results showed that since 1931, publications document 13 families with 31 affected infants (11 probands; 20 affected siblings). The median age at symptom onset for all affected infants was 3 months (range 0-6 months) with significant correlation (R = 0.60, P = 0.04) between probands and affected siblings. The median age at death for all affected infants was 6 months (range 1.5-13 months); probands were slightly older at death than their siblings. The median length of disease course for all affected infants was 3 months (0-10 months) and was slightly longer for probands. Unlike late-onset Pompe disease, there appears to be minimal phenotypic and lifespan variation among siblings with infantile Pompe disease. This prognostic information is vital for families with affected infants and allows for appropriate genetic counseling.
Collapse
Affiliation(s)
- Wendy E Smith
- Division of Genetics, The Barbara Bush Children's Hospital, Maine Medical Center, Portland, Maine, USA.
| | | | | | | | | | | | | |
Collapse
|
31
|
Affiliation(s)
- L Dienes
- Department of Pathology and Bacteriology of the Massachusetts General Hospital and the R. W. Lovett Memorial of Harvard Medical School, Boston, Mass
| | | |
Collapse
|
32
|
Affiliation(s)
- W E Smith
- Rockefeller Institute for Medical Research, New York, N. Y
| | | | | |
Collapse
|
33
|
Cunningham D, Littleford RE, Smith WE, Lundahl PJ, Khan I, McComb DW, Graham D, Laforest N. Practical control of SERRS enhancement. Faraday Discuss 2006; 132:135-45; discussion 147-58. [PMID: 16833113 DOI: 10.1039/b506241a] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The demonstration that quantitative and sensitive analysis can be carried out using surface enhanced resonance Raman scattering (SERRS) prompted a discussion and investigation of the main variables which are within the control of the analyst using colloidal silver as the substrate. Previous papers have dealt with the crucial need to obtain good chemisorption of the analyte to the surface and have reported the use of specially designed dyes for SERRS. One of the most variable processes is the aggregation of the colloid. Here, we investigate the addition of controlled amounts of an organic aggregating agent, poly-L-lysine, at concentrations which reduce the zeta potential in a controlled manner, thus aiding aggregation control. The relationship between the excitation frequency, the surface plasmon resonance frequency of the silver colloid and the frequency of the maximum absorbance of the molecular chromophore is studied using low concentrations of dye and no aggregating agent. Under these conditions, little to no aggregation is expected. The magnitude of the enhancement is strongly dependent on the frequency of the molecular chromophore as well as the plasmon resonance frequency. However, when sodium chloride is used to aggregate the colloid, a larger enhancement is obtained and the strong dependence on the molecular chromophore largely disappears. A much broader enhancement profile is obtained which appears to be related more to the specific enhancement processes caused by aggregation than the frequency of the chromophore. However, the total enhancement for SERRS is higher than for SERS thus indicating that the chromophore is still important to the process.
Collapse
Affiliation(s)
- D Cunningham
- University of Strathclyde, Dept. Pure & Applied Chemistry, 295 Cathedral Street, Glasgow, UK
| | | | | | | | | | | | | | | |
Collapse
|
34
|
McDermott DA, Bressan MC, He J, Lee JS, Aftimos S, Brueckner M, Gilbert F, Graham GE, Hannibal MC, Innis JW, Pierpont ME, Raas-Rothschild A, Shanske AL, Smith WE, Spencer RH, St John-Sutton MG, van Maldergem L, Waggoner DJ, Weber M, Basson CT. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res 2005; 58:981-6. [PMID: 16183809 DOI: 10.1203/01.pdr.0000182593.95441.64] [Citation(s) in RCA: 103] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Holt-Oram syndrome (HOS) is an autosomal dominant heart-hand syndrome characterized by congenital heart disease (CHD) and upper limb deformity, and caused by mutations in the TBX5 gene. To date, the sensitivity of TBX5 genetic testing for HOS has been unclear. We now report mutational analyses of a nongenetically selected population of 54 unrelated individuals who were consecutively referred to our center with a clinical diagnosis of HOS. TBX5 mutational analyses were performed in all individuals, and clinical histories and findings were reviewed for each patient without reference to the genotypes. Twenty-six percent of the complete cohort was shown to have mutations of the TBX5 gene. However, among those subjects for whom clinical review demonstrated that their presentations met strict diagnostic criteria for HOS, TBX5 mutations were identified in 74%. No mutations were identified in those subjects who did not meet these criteria. Thus, these studies validate our clinical diagnostic criteria for HOS including an absolute requirement for preaxial radial ray upper limb malformation. Accordingly, TBX5 genotyping has high sensitivity and specificity for HOS if stringent diagnostic criteria are used in assigning the clinical diagnosis.
Collapse
Affiliation(s)
- Deborah A McDermott
- Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Abstract
Inherited metabolic diseases are rare causes of neonatal morbidity, but they are associated with significant recurrence risks for the parents. Prompt identification and treatment of an infant with an inherited metabolic disease can minimize morbidity, mortality, and lifelong developmental problems. Diagnosis often requires specialized laboratory testing, but common laboratory tests can help identify those infants needing further evaluation. This paper reviews the laboratory abnormalities which can be found in various inherited metabolic diseases and can guide selection of specialized metabolic testing. Consultation with a metabolic specialist is essential for timely diagnosis and treatment to ensure the best possible outcome.
Collapse
Affiliation(s)
- Cheryl L Garganta
- Division of Genetics, Department of Pediatrics, Tufts-New England Medical Center, Boston, MA 02111, USA.
| | | |
Collapse
|
36
|
Jordan P, Cooper J, McNay G, Docherty FT, Smith WE, Sinclair G, Padgett MJ. Three-dimensional optical trapping of partially silvered silica microparticles. Opt Lett 2004; 29:2488-2490. [PMID: 15584270 DOI: 10.1364/ol.29.002488] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
We demonstrate three-dimensional trapping of micrometer-diameter silica particles, partially coated with silver, within conventional optical tweezers. Although metallic particles are usually repelled from the beam focus by the scattering force, we show that transparent spheres partially coated with silver can be trapped with efficiencies comparable with dielectric particles. The trapping characteristics of these particles are examined as a function of metallic coverage, and the application of these particles to surface-enhanced resonance Raman scattering is investigated.
Collapse
Affiliation(s)
- P Jordan
- Department of Electronic and Electrical Engineering, University of Glasgow, Scotland G12 8LT, UK.
| | | | | | | | | | | | | |
Collapse
|
37
|
Mills A, Hill G, Stewart M, Graham D, Smith WE, Hodgen S, Halfpenny PJ, Faulds K, Robertson P. Characterization of novel Ag on TiO2 films for surface-enhanced Raman scattering. Appl Spectrosc 2004; 58:922-928. [PMID: 18070385 DOI: 10.1366/0003702041655520] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Novel Ag on TiO2 films are generated by semiconductor photocatalysis and characterized by ultraviolet-visible (UV/Vis) spectroscopy, scanning electron microscopy (SEM), and atomic force microscopy (AFM), as well as assessed for surface-enhanced Raman scattering (SERS) activity. The nature and thickness of the photodeposited Ag, and thus the degree of SERS activity, is controlled by the time of exposure of the TiO2 film to UV light. All such films exhibit the optical characteristics (lambda(max) congruent with 390 nm) of small (< 20 nm) Ag particles, although this feature becomes less prominent as the film becomes thicker. The films comprise quite large (> 40 nm) Ag islands that grow and merge with increasing levels of Ag photodeposition. Tested with a benzotriazole dye probe, the films are SERS active, exhibiting activity similar to that of 6-nm-thick vapor-deposited films. The Ag/TiO2 films exhibit a lower residual standard deviation (approximately 25%) compared with Ag vapor-deposited films (approximately 45%), which is, however, still unacceptable for quantitative work. The sample-to-sample variance could be reduced significantly (< 7%) by spinning the film during the SERS measurement. The Ag/TiO2 films are mechanically robust and resistant to removal and damage by scratching, unlike the Ag vapor-deposited films. The Ag/TiO2 films also exhibit no obvious loss of SERS activity when stored in the dark under otherwise ambient conditions. The possible extension of this simple, effective method of producing Ag films for SERS, to metals other than Ag and to semiconductors other than TiO2, is briefly discussed.
Collapse
Affiliation(s)
- A Mills
- Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, U.K
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Abstract
Resonance Raman scattering from cytochrome P450 BM3 is obtained with a Raman microprobe using 406-nm excitation with an accumulation time of a few seconds. The small sample size and rapid measurement time make the routine characterization of P450 systems by resonance Raman spectroscopy easier. Addition of imidazole and imidazole derivatives as inhibitors causes the appearance of additional peaks due to vinyl modes, increases the relative intensity of symmetric modes that would be A(1g) in D(4h) symmetry, and causes a large drop in the intensity of nu(11). This information indicates that the ligation of imidazoles to the heme iron causes the alignment of the vinyl modes with the plane of the heme ring and reduces the out of plane distortion of the ring. The effect of both inhibitors is similar but there is a subtle difference in the extent of the reduction in the intensity of nu(11), which suggests that steric effects within the pocket are having some effect.
Collapse
Affiliation(s)
- S J Smith
- Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building, 295 Cathedral Street, Glasgow G1 1XL, United Kingdom
| | | | | |
Collapse
|
39
|
Ensenauer RE, Adeyinka A, Flynn HC, Michels VV, Lindor NM, Dawson DB, Thorland EC, Lorentz CP, Goldstein JL, McDonald MT, Smith WE, Simon-Fayard E, Alexander AA, Kulharya AS, Ketterling RP, Clark RD, Jalal SM. Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 2003; 73:1027-40. [PMID: 14526392 PMCID: PMC1180483 DOI: 10.1086/378818] [Citation(s) in RCA: 253] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2003] [Accepted: 07/29/2003] [Indexed: 11/03/2022] Open
Abstract
Chromosome 22, particularly band 22q11.2, is predisposed to rearrangements due to misalignments of low-copy repeats (LCRs). DiGeorge/velocardiofacial syndrome (DG/VCFS) is a common disorder resulting from microdeletion within the same band. Although both deletion and duplication are expected to occur in equal proportions as reciprocal events caused by LCR-mediated rearrangements, very few microduplications have been identified. We have identified 13 cases of microduplication 22q11.2, primarily by interphase fluorescence in situ hybridization (FISH). The size of the duplications, determined by FISH probes from bacterial artificial chromosomes and P(1) artificial chromosomes, range from 3-4 Mb to 6 Mb, and the exchange points seem to involve an LCR. Molecular analysis based on 15 short tandem repeats confirmed the size of the duplications and indicated that at least 1 of 15 loci has three alleles present. The patients' phenotypes ranged from mild to severe, sharing a tendency for velopharyngeal insufficiency with DG/VCFS but having other distinctive characteristics, as well. Although the present series of patients was ascertained because of some overlapping features with DG/VCF syndromes, the microduplication of 22q11.2 appears to be a new syndrome.
Collapse
Affiliation(s)
- Regina E. Ensenauer
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Adewale Adeyinka
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Heather C. Flynn
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Virginia V. Michels
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Noralane M. Lindor
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - D. Brian Dawson
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Erik C. Thorland
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Cindy Pham Lorentz
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Jennifer L. Goldstein
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Marie T. McDonald
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Wendy E. Smith
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Elba Simon-Fayard
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Alan A. Alexander
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Anita S. Kulharya
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Rhett P. Ketterling
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Robin D. Clark
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| | - Syed M. Jalal
- Department of Medical Genetics, and Cytogenetics Laboratory and Molecular Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pediatrics, Duke University Medical Center, Durham, NC; Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME; Department of Pediatrics, Division of Neonatology, Loma Linda University Medical Center, and Division of Genetics, Loma Linda University Children’s Hospital, Loma Linda, CA; Desert Pediatrics, Inc., Palm Desert, CA; and Department of Pediatrics and Pathology, Medical College of Georgia, Augusta, GA
| |
Collapse
|
40
|
Littleford RE, Hughes MP, Dent G, Tackley D, Smith WE. Surface-enhanced resonance Raman scattering of black inkjet dyes in solution and in situ printed onto paper. Appl Spectrosc 2003; 57:977-983. [PMID: 14661841 DOI: 10.1366/000370203322258940] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Understanding the changes that occur when dyes are absorbed onto paper is crucial for the design of new inkjet dyes. This problem is particularly difficult for black dyes that have complex chromophores, and as a result, spectroscopic information on electronic and structural changes can be of importance. Surface-enhanced resonance Raman scattering (SERRS) and electronic structure calculations were used to probe in situ changes in the chromophore in black di-azo dyes printed onto paper. The data indicate that the low-energy chromophore is due mainly to the hydrazone group and the high-energy chromophore to both the azo and hydrazone groups. A comparison of SERRS from the dyes adsorbed onto silver particles in suspension and from the dyes on paper demonstrated a broadening of the chromophore into the red for both dyes and evidence of a structural change in one dye.
Collapse
Affiliation(s)
- R E Littleford
- University of Strathclyde, Department of Pure and Applied Chemistry, 295 Cathedral Street, Glasgow G1 1XL, Scotland, UK
| | | | | | | | | |
Collapse
|
41
|
Koeberl DD, Young SP, Gregersen NS, Vockley J, Smith WE, Benjamin DK, An Y, Weavil SD, Chaing SH, Bali D, McDonald MT, Kishnani PS, Chen YT, Millington DS. Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. Pediatr Res 2003; 54:219-23. [PMID: 12736383 DOI: 10.1203/01.pdr.0000074972.36356.89] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Tandem mass spectrometry was adopted for newborn screening by North Carolina in April 1999. Since then, three infants with short-chain acyl-CoA dehydrogenase (SCAD) and one with isobutyryl-CoA dehydrogenase deficiency were detected on the basis of elevated butyrylcarnitine/isobutyrylcarnitine (C4-carnitine) concentrations in newborn blood spots analyzed by tandem mass spectrometry. For three SCAD-deficient infants, biochemical evaluation included a plasma acylcarnitine profile with markedly elevated C4-carnitine, urine organic acid analysis with markedly elevated ethylmalonic and 2-methylsuccinic acids, and markedly elevated [U-13C]butyrylcarnitine concentrations in medium from fibroblasts incubated with [U-13C]palmitic acid and excess l-carnitine, consistent with classic SCAD deficiency. Two of three infants diagnosed with classic SCAD deficiency remained asymptomatic; however, the third infant presented with seizures and a cerebral infarct at 10 wk of age. All three infants had putatively inactivating mutations in both alleles of the SCAD gene. The highly elevated plasma C4-carnitine levels in the three infants detected by newborn screening tandem mass spectrometry differentiated them from infants and children who were homozygous or compound heterozygous for one of two SCAD gene susceptibility variations; for the latter group the C4-carnitine levels were normal. Isobutyryl-CoA dehydrogenase deficiency in a fourth infant was confirmed after isolated elevation of C4-carnitine in the acylcarnitine profile.
Collapse
Affiliation(s)
- Dwight D Koeberl
- Division of Medical Genetics, DUMC 3528, Bell Building Room 237, Trent Duke University Medical Center, Durham, NC 27710, U.S.A.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Smith WE, Kane AV, Campbell ST, Acheson DWK, Cochran BH, Thorpe CM. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect Immun 2003; 71:1497-504. [PMID: 12595468 PMCID: PMC148871 DOI: 10.1128/iai.71.3.1497-1504.2003] [Citation(s) in RCA: 140] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Shiga toxins made by Shiga toxin-producing Escherichia coli (STEC) are associated with hemolytic uremic syndrome. Shiga toxins (Stxs) may access the host systemic circulation by absorption across the intestinal epithelium. The effects of Stxs on this cell layer are not completely understood, although animal models of STEC infection suggest that, in the gut, Stxs may participate in both immune activation and apoptosis. Stxs have one enzymatically active A subunit associated with five identical B subunits. The A subunit inactivates ribosomes by cleaving a specific adenine from the 28S rRNA. We have previously shown that Stxs can induce multiple C-X-C chemokines in intestinal epithelial cells in vitro, including interleukin-8 (IL-8), and that Stx-induced IL-8 expression is linked to induction of c-Jun mRNA and p38 mitogen-activated protein (MAP) kinase pathway activity. We now report Stx1 induction of both primary response genes c-jun and c-fos and activation of the stress-activated protein kinases, JNK/SAPK and p38, in the intestinal epithelial cell line HCT-8. By 1 h of exposure to Stx1, mRNAs for c-jun and c-fos are induced, and both JNK and p38 are activated; activation of both kinases persisted up to 24 h. Stx1 enzymatic activity was required for kinase activation; a catalytically defective mutant toxin did not activate either. Stx1 treatment of HCT-8 cells resulted in cell death that was associated with caspase 3 cleavage and internucleosomal DNA fragmentation; this cytotoxicity also required Stx1 enzymatic activity. Blocking Stx1-induced p38 and JNK activation with the inhibitor SB202190 prevented cell death and diminished Stx1-associated caspase 3 cleavage. In summary, these data link the Stx1-induced ribotoxic stress response with both chemokine expression and apoptosis in the intestinal epithelial cell line HCT-8 and suggest that blocking host cell MAP kinases may prevent these Stx-associated events.
Collapse
Affiliation(s)
- Wendy E Smith
- Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts--New England Medical Center, Boston, Massachusetts, USA
| | | | | | | | | | | |
Collapse
|
43
|
McAnally GD, Everall NJ, Chalmers JM, Smith WE. Analysis of thin film coatings on poly(ethylene terephthalate) by confocal Raman microscopy and surface-enhanced Raman scattering. Appl Spectrosc 2003; 57:44-50. [PMID: 14610935 DOI: 10.1366/000370203321165197] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
The characterization of thin coatings on polymers such as poly(ethylene terephthalate) (PET) is required in order to study chemical composition and coating continuity. Two different methods of applying Raman spectroscopy for this purpose are compared in this paper. Using confocal Raman microscopy, thick coatings (> 10 microns) are relatively easily identified; however, the Raman scattering from the acrylic coatings commonly used is much weaker than that of PET and consequently, there is a background due to the substrate. Thin acrylic coatings (< 1 micron) usually cannot be detected. Surface-enhanced Raman scattering (SERS) of uncoated PET gives intense signals and if the spectra are taken from the metal-coated side, there is no evidence of the underlying Raman scattering from the bulk. Acrylic coatings do not give sufficiently strong or reproducible SERS to be reliably identified, but even thin (20 nm) coatings completely block the SERS from the substrate. Only where gaps appear in the coating is the SERS of the underlying PET seen. To detect a positive signal from the coating, SERS active labels were incorporated into the acrylic at low concentrations either as a physical mixture or as reactive co-monomers. This uniquely labels the coating and allows detection and, in principle, mapping of the coverage. Thus, for thick (> > 1 micron) coatings, normal Raman spectroscopy is an effective technique for detecting the presence of the surface coating. However, it is ineffective with thin (< 1 micron) coatings, and SERS alone only indicates where the coating is incomplete or defective. However, when a SERS label is added, spectra can be detected from very thin coatings (20 nm). The concentration of the labels is sufficiently low for the coating to remain colorless.
Collapse
Affiliation(s)
- G D McAnally
- Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK G1 1XL
| | | | | | | |
Collapse
|
44
|
Koeberl DD, Millington DS, Smith WE, Weavil SD, Muenzer J, McCandless SE, Kishnani PS, McDonald MT, Chaing S, Boney A, Moore E, Frazier DM. Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening. J Inherit Metab Dis 2003; 26:25-35. [PMID: 12872837 DOI: 10.1023/a:1024015227863] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Since the addition of tandem mass spectrometry (MS/MS) to the North Carolina Newborn Screening Program, 20 infants with two consecutive elevated 3-hydroxyisovalerylcarnitine (C5OH) levels have been evaluated for evidence of inborn errors of metabolism associated with this metabolite. Ten of these 20 infants had significant concentrations of both 3-hydroxyisovaleric acid and 3-methylcrotonylglycine in their urine, suggestive of 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency. Four of these 10 were infants whose abnormal metabolites were found to be of maternal origin. Of 8 patients with probable 3-MCC deficiency, 7 have been tested and found to have the enzyme deficiency confirmed in lymphoblasts or cultured fibroblasts; one of these 7 infants had only marginally decreased 3-MCC activity in lymphocytes but deficient 3-MCC in fibroblasts. We estimate the incidence of 3-MCC deficiency at 1:64000 live births in North Carolina. We conclude that MS/MS newborn screening will detect additional inborn errors of metabolism, such as 3-MCC deficiency, not traditionally associated with newborn screening. The evaluation of newborns with two abnormally elevated C5OH levels on MS/MS newborn screening should include, at least, urine organic acid analysis by capillary GC-MS and a plasma acylcarnitine profile by MS/MS. Long-term follow-up is needed to determine the outcome of presymptomatically diagnosed patients with 3-MCC deficiency by MS/MS newborn screening.
Collapse
Affiliation(s)
- D D Koeberl
- Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Faulds K, Smith WE, Graham D, Lacey RJ. Assessment of silver and gold substrates for the detection of amphetamine sulfate by surface enhanced Raman scattering (SERS). Analyst 2002; 127:282-6. [PMID: 11913874 DOI: 10.1039/b107318b] [Citation(s) in RCA: 110] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Methods of detection of amphetamine sulfate using surface enhanced Raman scattering (SERS) from colloidal suspensions and vapour deposited films of both silver and gold are compared. Different aggregating agents are required to produce effective SERS from silver and gold colloidal suspensions. Gold colloid and vapour deposited gold films give weaker scattering than the equivalent silver substrates when high concentrations of drug are analysed but they also give lower detection limits, suggesting a smaller surface enhancement but stronger surface adsorption. A 10(-5) mol dm(-3) solution (the final concentration after addition of colloid was 10(-6) mol dm(-3)) of amphetamine sulfate was detected from gold colloid with an RSD of 5.4%. 25 microl of the same solution could be detected on a roughened gold film. The intensities of the spectra varied across the film surface resulting in relatively high RSDs. The precision was improved by averaging the scattering from several points on the surface. An attempt to improve the detection limit and precision by concentrating a suspension of gold colloid and amphetamine sulfate in aluminium wells did not give effective quantitation. Thus, positive identification and semi-quantitative estimation of amphetamine sulfate can be made quickly and easily using SERS from suspended gold colloid with the appropriate aggregating agents.
Collapse
Affiliation(s)
- K Faulds
- Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK
| | | | | | | |
Collapse
|
46
|
Smith WE. Mormon sex standards on college campuses: or deal us out of the sexual revolution! Dialogue 2001; 10:76-81. [PMID: 11614391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
47
|
Thorpe CM, Smith WE, Hurley BP, Acheson DW. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun 2001; 69:6140-7. [PMID: 11553553 PMCID: PMC98744 DOI: 10.1128/iai.69.10.6140-6147.2001] [Citation(s) in RCA: 120] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2001] [Accepted: 06/22/2001] [Indexed: 11/20/2022] Open
Abstract
Exposure of humans to Shiga toxins (Stxs) is a risk factor for hemolytic-uremic syndrome (HUS). Because Stx-producing Escherichia coli (STEC) is a noninvasive enteric pathogen, the extent to which Stxs can cross the host intestinal epithelium may affect the risk of developing HUS. We have previously shown that Stxs can induce and superinduce IL-8 mRNA and protein in intestinal epithelial cells (IECs) in vitro via a ribotoxic stress response. We used cytokine expression arrays to determine the effect of Stx1 on various C-X-C chemokine genes in IECs. We observed that Stx1 induces multiple C-X-C chemokines at the mRNA level, including interleukin-8 (IL-8), GRO-alpha, GRO-beta, GRO-gamma, and ENA-78. Like that of IL-8, GRO-alpha and ENA-78 mRNAs are both induced and superinduced by Stx1. Furthermore, Stx1 induces both IL-8 and GRO-alpha protein in a dose-response fashion, despite an overall inhibition in host cell protein synthesis. Stx1 treatment stabilizes both IL-8 and GRO-alpha mRNA. We conclude that Stxs are able to increase mRNA and protein levels of multiple C-X-C chemokines in IECs, with increased mRNA stability at least one mechanism involved. We hypothesize that ribotoxic stress is a pathway by which Stxs can alter host signal transduction in IECs, resulting in the production of multiple chemokine mRNAs, leading to increased expression of specific proteins. Taken together, these data suggest that exposing IECs to Stxs may stimulate a proinflammatory response, resulting in influx of acute inflammatory cells and thus contributing to the intestinal tissue damage seen in STEC infection.
Collapse
Affiliation(s)
- C M Thorpe
- Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts, USA.
| | | | | | | |
Collapse
|
48
|
Abstract
We report 2 patients with confirmed Niemann-Pick disease, type B, with previous diagnoses of glycogen storage disease based on excessive glycogen on liver biopsy specimens. These cases emphasize the importance of a complete evaluation, including biochemical confirmation, for patients with suspected metabolic storage diseases.
Collapse
Affiliation(s)
- W E Smith
- Department of Pediatrics, Duke University Medical Center, DUMC 3528 Bell Building, Trent Dr., Durham, NC 27710, USA
| | | | | | | | | | | |
Collapse
|
49
|
Smith WE, Millington DS, Koeberl DD, Lesser PS. Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics 2001; 107:1184-7. [PMID: 11331707 DOI: 10.1542/peds.107.5.1184] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
We report a child initially diagnosed with promethazine-induced dystonia despite a lack of response to diphenhydramine therapy. On further evaluation, the child was diagnosed with glutaric acidemia, type I (GA-I), an autosomal recessive inborn error of metabolism caused by the deficiency of glutaryl-CoA dehydrogenase. The characteristic clinical feature of GA-I is an acute encephalopathic and neurologic crisis typically occurring during a catabolic state. Despite slow improvement, many patients do not fully recover from a neurologic crisis, and residual neurologic morbidity can be significant. Although newborn screening using tandem mass spectrometry is expected to enable presymptomatic diagnosis of GA-I, this patient was not detected by newborn screening with tandem mass spectrometry. Therefore, a high suspicion of GA-I must be maintained in the evaluation of childhood dystonia, even when newborn screening results are reportedly normal.
Collapse
Affiliation(s)
- W E Smith
- Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
| | | | | | | |
Collapse
|
50
|
Smith WE, Rungis J. Twin adhering conducting spheres in an electric field-an alternative geometry for an electrostatic voltmeter. ACTA ACUST UNITED AC 2001. [DOI: 10.1088/0022-3735/8/5/013] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|